Marrone Bio Innovations, Inc.
- Jurisdiction
United States - LEI
54930082ZJZ17VOHI543 - ISIN
US57165B1061 (MBII )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Read full profile
Fundamentals
- Net revenue
€37.84M - Gross margin
59.7% - EBIT
-€15.93M - EBIT margin
-42.1% - Net income
-€17.82M - Net margin
-47.1%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: May 11, 2022 (Q1 2022)